LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384

American Journal of Cancer Research

Volumn 6, Issue 10, 2016, Pages 2299-2309

  Chen, Zili ^a   Yu, Chao ^a   Zhan, Lei ^a   Pan, Yaozhen ^a   Chen, Ling ^a   Sun, Chengyi ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; lncRNA CRNDE; Migration and invasion; MiR 384

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 384; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL TUMOR; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CANCER CELL LINE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RNA BINDING; UPREGULATION;

EID: 84995687689     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Woerns MA, Weinmann A, Schuchmann M and Galle PR. Systemic therapies in hepatocellular carcinoma. Dig Dis 2009; 27: 175-188
2. Spangenberg HC, Thimme R and Blum HE. Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009; 6: 423-432
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
4. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W and Amano J. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000; 191: 381-388
5. Wapinski O and Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361
6. Guttman M and Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012; 482: 339-346
7. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Morales DR, Thomas K, Presser A, Bernstein BE and van Oudenaarden A. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci 2009; 106: 11667-11672
8. Zhao W, An Y, Liang Y and Xie X. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur Rev Med Pharmacol Sci 2014; 18: 1930-1936
9. Mercer TR, Dinger ME and Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10: 155-159
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233
11. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714
12. Sharma S, Kelly TK and Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31: 27-36
13. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B and Bao JK. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45: 487-498
14. El-Serag HB and Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750
15. Lupberger J and Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007; 13: 74
16. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-235
17. Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N and Aoyagi S. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002; 131: 300-310
18. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Hashimoto K, Tangoku A and Hamada K. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 2003; 22: 3007-3014
19. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS and Qu J. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci 2001; 98: 15089-15094
20. Wu TT, Hsieh YH, Hsieh YS and Liu JY. Reduction of PKCa decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 2008; 103: 9-20
21. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D and Anania FA. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 2007; 67: 2497-2507
22. Zamore PD and Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309: 1519-1524
23. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866
24. Coulouarn C, Factor VM, Andersen JB, Durkin ME and Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009; 28: 3526-3536
25. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F and Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-5383
26. He X, Chang Y, Meng F, Wang M, Xie Q, Tang F, Li P, Song Y and Lin J. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012; 31: 3357-3369
27. Qiu MT, Hu JW, Yin R and Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumor Biol 2013; 34: 613-620
28. Eades G, Zhang YS, Li QL, Xia JX, Yao Y and Zhou Q. Long non-coding RNAs in stem cells and cancer. World J Clin Oncol 2014; 5: 134-141
29. Liz J and Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta 2016; 1859: 169-176
30. Tay Y, Rinn J and Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344-352
31. Karin M. NF-κB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009; 1: a000141
32. Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P and Kim SY. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 2009; 16: 21-32